APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

In-Vitro Diagnostics

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

Selected research

Market Analysis & Forecast

Global In-Vitro Diagnostics Market Analysis and Forecast 2026-2032

25 December 2025203 pages

Choose your research edition.

Industry ResearchIn-Vitro Diagnostics Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal In-Vitro Diagnostics Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal In-Vitro Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In-Vitro Diagnostics Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal In-Vitro Diagnostics Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 7% of the whole market.

Report Includes

Read the full market overview

This report presents an overview of global market for In-Vitro Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of In-Vitro Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for In-Vitro Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the In-Vitro Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for In-Vitro Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

In-Vitro Diagnostics Segment by Company

Roche

Siemens

Abbott

Danaher

Thermo Fisher

BioMerieux

Bio-Rad

BD

JNJ

Sysmex

KHB

DaAn Gene

Leadman

BioSino

BSBE

Maccura

In-Vitro Diagnostics Segment by Type

Tissue Diagnostics

Professional Diagnostic

Molecular Diagnostic

Diabetes Monitoring

Other

In-Vitro Diagnostics Segment by Application

Diabetes

Infectious Diseases

Oncology

Cardiology

HIV

Other

In-Vitro Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of In-Vitro Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of In-Vitro Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Vitro Diagnostics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tissue Diagnostics Major Player Table 3. Professional Diagnostic Major Player Table 4. Molecular Diagnostic Major Player Table 5. Diabetes Monitoring Major Player Table 6. Other Major Player Table 7. Global In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Diabetes Major Player Table 9. Infectious Diseases Major Player Table 10. Oncology Major Player Table 11. Cardiology Major Player Table 12. HIV Major Player Table 13. Other Major Player Table 14. In-Vitro Diagnostics Industry Trends Table 15. In-Vitro Diagnostics Industry Drivers Table 16. In-Vitro Diagnostics Industry Opportunities and Challenges Table 17. In-Vitro Diagnostics Industry Restraints Table 18. Global In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global In-Vitro Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 20. Global In-Vitro Diagnostics Market Share by Region (2021-2026) Table 21. Global In-Vitro Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 22. Global In-Vitro Diagnostics Market Share by Region (2027-2032) Table 23. Global In-Vitro Diagnostics Revenue by Players (US$ Million) & (2021-2026) Table 24. Global In-Vitro Diagnostics Revenue Market Share by Players (2021-2026) Table 25. Global In-Vitro Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global In-Vitro Diagnostics Key Players Headquarters & Area Served Table 27. Global In-Vitro Diagnostics Players, Product Type & Application Table 28. Global In-Vitro Diagnostics Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global In-Vitro Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global In-Vitro Diagnostics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global In-Vitro Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 33. Global In-Vitro Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 34. Global In-Vitro Diagnostics Revenue Market Share by Type (2021-2026) Table 35. Global In-Vitro Diagnostics Revenue Market Share by Type (2027-2032) Table 36. Global In-Vitro Diagnostics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global In-Vitro Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 38. Global In-Vitro Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 39. Global In-Vitro Diagnostics Revenue Market Share by Application (2021-2026) Table 40. Global In-Vitro Diagnostics Revenue Market Share by Application (2027-2032) Table 41. Roche Company Information Table 42. Roche Business Overview Table 43. Roche In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Roche In-Vitro Diagnostics Product Portfolio Table 45. Roche Recent Development Table 46. Siemens Company Information Table 47. Siemens Business Overview Table 48. Siemens In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Siemens In-Vitro Diagnostics Product Portfolio Table 50. Siemens Recent Development Table 51. Abbott Company Information Table 52. Abbott Business Overview Table 53. Abbott In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Abbott In-Vitro Diagnostics Product Portfolio Table 55. Abbott Recent Development Table 56. Danaher Company Information Table 57. Danaher Business Overview Table 58. Danaher In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Danaher In-Vitro Diagnostics Product Portfolio Table 60. Danaher Recent Development Table 61. Thermo Fisher Company Information Table 62. Thermo Fisher Business Overview Table 63. Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Thermo Fisher In-Vitro Diagnostics Product Portfolio Table 65. Thermo Fisher Recent Development Table 66. BioMerieux Company Information Table 67. BioMerieux Business Overview Table 68. BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. BioMerieux In-Vitro Diagnostics Product Portfolio Table 70. BioMerieux Recent Development Table 71. Bio-Rad Company Information Table 72. Bio-Rad Business Overview Table 73. Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Bio-Rad In-Vitro Diagnostics Product Portfolio Table 75. Bio-Rad Recent Development Table 76. BD Company Information Table 77. BD Business Overview Table 78. BD In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. BD In-Vitro Diagnostics Product Portfolio Table 80. BD Recent Development Table 81. JNJ Company Information Table 82. JNJ Business Overview Table 83. JNJ In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. JNJ In-Vitro Diagnostics Product Portfolio Table 85. JNJ Recent Development Table 86. Sysmex Company Information Table 87. Sysmex Business Overview Table 88. Sysmex In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Sysmex In-Vitro Diagnostics Product Portfolio Table 90. Sysmex Recent Development Table 91. KHB Company Information Table 92. KHB Business Overview Table 93. KHB In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. KHB In-Vitro Diagnostics Product Portfolio Table 95. KHB Recent Development Table 96. DaAn Gene Company Information Table 97. DaAn Gene Business Overview Table 98. DaAn Gene In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. DaAn Gene In-Vitro Diagnostics Product Portfolio Table 100. DaAn Gene Recent Development Table 101. Leadman Company Information Table 102. Leadman Business Overview Table 103. Leadman In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Leadman In-Vitro Diagnostics Product Portfolio Table 105. Leadman Recent Development Table 106. BioSino Company Information Table 107. BioSino Business Overview Table 108. BioSino In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. BioSino In-Vitro Diagnostics Product Portfolio Table 110. BioSino Recent Development Table 111. BSBE Company Information Table 112. BSBE Business Overview Table 113. BSBE In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. BSBE In-Vitro Diagnostics Product Portfolio Table 115. BSBE Recent Development Table 116. Maccura Company Information Table 117. Maccura Business Overview Table 118. Maccura In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Maccura In-Vitro Diagnostics Product Portfolio Table 120. Maccura Recent Development Table 121. North America In-Vitro Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 122. North America In-Vitro Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 123. North America In-Vitro Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 124. North America In-Vitro Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 125. North America In-Vitro Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America In-Vitro Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 127. North America In-Vitro Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 128. Europe In-Vitro Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe In-Vitro Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe In-Vitro Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe In-Vitro Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe In-Vitro Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe In-Vitro Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 134. Europe In-Vitro Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 135. China In-Vitro Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 136. China In-Vitro Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 137. China In-Vitro Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 138. China In-Vitro Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia In-Vitro Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia In-Vitro Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia In-Vitro Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia In-Vitro Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia In-Vitro Diagnostics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia In-Vitro Diagnostics Revenue by Region (US$ Million) & (2021-2026) Table 145. Asia In-Vitro Diagnostics Revenue by Region (US$ Million) & (2027-2032) Table 146. SAMEA In-Vitro Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA In-Vitro Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA In-Vitro Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 149. SAMEA In-Vitro Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 150. SAMEA In-Vitro Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. SAMEA In-Vitro Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 152. SAMEA In-Vitro Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. In-Vitro Diagnostics Image Figure 2. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global In-Vitro Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tissue Diagnostics Image Figure 5. Professional Diagnostic Image Figure 6. Molecular Diagnostic Image Figure 7. Diabetes Monitoring Image Figure 8. Other Image Figure 9. Global In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global In-Vitro Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 11. Diabetes Image Figure 12. Infectious Diseases Image Figure 13. Oncology Image Figure 14. Cardiology Image Figure 15. HIV Image Figure 16. Other Image Figure 17. Global In-Vitro Diagnostics Market Size (US$ Million) & (2021-2032) Figure 18. Global In-Vitro Diagnostics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global In-Vitro Diagnostics Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global In-Vitro Diagnostics Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global In-Vitro Diagnostics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global In-Vitro Diagnostics Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global In-Vitro Diagnostics Revenue Market Share by Type (2021-2032) Figure 25. Global In-Vitro Diagnostics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global In-Vitro Diagnostics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global In-Vitro Diagnostics Revenue Market Share by Application (2021-2032) Figure 28. North America In-Vitro Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America In-Vitro Diagnostics Revenue Share by Type (2021-2032) Figure 30. North America In-Vitro Diagnostics Revenue Share by Application (2021-2032) Figure 31. North America In-Vitro Diagnostics Revenue Share by Country (2021-2032) Figure 32. United States In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe In-Vitro Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe In-Vitro Diagnostics Revenue Share by Type (2021-2032) Figure 37. Europe In-Vitro Diagnostics Revenue Share by Application (2021-2032) Figure 38. Europe In-Vitro Diagnostics Revenue Share by Country (2021-2032) Figure 39. Germany In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China In-Vitro Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China In-Vitro Diagnostics Revenue Share by Type (2021-2032) Figure 49. China In-Vitro Diagnostics Revenue Share by Application (2021-2032) Figure 50. Asia In-Vitro Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia In-Vitro Diagnostics Revenue Share by Type (2021-2032) Figure 52. Asia In-Vitro Diagnostics Revenue Share by Application (2021-2032) Figure 53. Asia In-Vitro Diagnostics Revenue Share by Region (2021-2032) Figure 54. Japan In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA In-Vitro Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA In-Vitro Diagnostics Revenue Share by Type (2021-2032) Figure 62. SAMEA In-Vitro Diagnostics Revenue Share by Application (2021-2032) Figure 63. SAMEA In-Vitro Diagnostics Revenue Share by Country (2021-2032) Figure 64. Brazil In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt In-Vitro Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Tissue Diagnostics
  • Professional Diagnostic
  • Molecular Diagnostic
  • Diabetes Monitoring
  • Other
Applications
  • Diabetes
  • Infectious Diseases
  • Oncology
  • Cardiology
  • HIV
  • Other
Companies covered
  • Roche
  • Siemens
  • Abbott
  • Danaher
  • Thermo Fisher
  • BioMerieux
  • Bio-Rad
  • BD
  • JNJ
  • Sysmex
  • KHB
  • DaAn Gene
  • Leadman
  • BioSino
  • BSBE
  • Maccura

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 In-Vitro Diagnostics Market by Type
  3. 1.2.1 Global In-Vitro Diagnostics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tissue Diagnostics
  5. 1.2.3 Professional Diagnostic
  6. 1.2.4 Molecular Diagnostic
  7. 1.2.5 Diabetes Monitoring
  8. 1.2.6 Other
  9. 1.3 In-Vitro Diagnostics Market by Application
  10. 1.3.1 Global In-Vitro Diagnostics Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Diabetes
  12. 1.3.3 Infectious Diseases
  13. 1.3.4 Oncology
  14. 1.3.5 Cardiology
  15. 1.3.6 HIV
  16. 1.3.7 Other
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 In-Vitro Diagnostics Market Dynamics
  1. 2.1 In-Vitro Diagnostics Industry Trends
  2. 2.2 In-Vitro Diagnostics Industry Drivers
  3. 2.3 In-Vitro Diagnostics Industry Opportunities and Challenges
  4. 2.4 In-Vitro Diagnostics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global In-Vitro Diagnostics Market Perspective (2021-2032)
  2. 3.2 Global In-Vitro Diagnostics Growth Trends by Region
  3. 3.2.1 Global In-Vitro Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global In-Vitro Diagnostics Market Size by Region (2021-2026)
  5. 3.2.3 Global In-Vitro Diagnostics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global In-Vitro Diagnostics Revenue by Players
  2. 4.1.1 Global In-Vitro Diagnostics Revenue by Players (2021-2026)
  3. 4.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global In-Vitro Diagnostics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global In-Vitro Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global In-Vitro Diagnostics Key Players Headquarters & Area Served
  7. 4.4 Global In-Vitro Diagnostics Players, Product Type & Application
  8. 4.5 Global In-Vitro Diagnostics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global In-Vitro Diagnostics Market CR5 and HHI
  11. 4.6.3 2025 In-Vitro Diagnostics Tier 1, Tier 2, and Tier 3
5 In-Vitro Diagnostics Market Size by Type
  1. 5.1 Global In-Vitro Diagnostics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global In-Vitro Diagnostics Revenue by Type (2021-2032)
  3. 5.3 Global In-Vitro Diagnostics Revenue Market Share by Type (2021-2032)
6 In-Vitro Diagnostics Market Size by Application
  1. 6.1 Global In-Vitro Diagnostics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global In-Vitro Diagnostics Revenue by Application (2021-2032)
  3. 6.3 Global In-Vitro Diagnostics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Roche In-Vitro Diagnostics Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Siemens
  8. 7.2.1 Siemens Company Information
  9. 7.2.2 Siemens Business Overview
  10. 7.2.3 Siemens In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Siemens In-Vitro Diagnostics Product Portfolio
  12. 7.2.5 Siemens Recent Developments
  13. 7.3 Abbott
  14. 7.3.1 Abbott Company Information
  15. 7.3.2 Abbott Business Overview
  16. 7.3.3 Abbott In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Abbott In-Vitro Diagnostics Product Portfolio
  18. 7.3.5 Abbott Recent Developments
  19. 7.4 Danaher
  20. 7.4.1 Danaher Company Information
  21. 7.4.2 Danaher Business Overview
  22. 7.4.3 Danaher In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Danaher In-Vitro Diagnostics Product Portfolio
  24. 7.4.5 Danaher Recent Developments
  25. 7.5 Thermo Fisher
  26. 7.5.1 Thermo Fisher Company Information
  27. 7.5.2 Thermo Fisher Business Overview
  28. 7.5.3 Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
  30. 7.5.5 Thermo Fisher Recent Developments
  31. 7.6 BioMerieux
  32. 7.6.1 BioMerieux Company Information
  33. 7.6.2 BioMerieux Business Overview
  34. 7.6.3 BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
  36. 7.6.5 BioMerieux Recent Developments
  37. 7.7 Bio-Rad
  38. 7.7.1 Bio-Rad Company Information
  39. 7.7.2 Bio-Rad Business Overview
  40. 7.7.3 Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
  42. 7.7.5 Bio-Rad Recent Developments
  43. 7.8 BD
  44. 7.8.1 BD Company Information
  45. 7.8.2 BD Business Overview
  46. 7.8.3 BD In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BD In-Vitro Diagnostics Product Portfolio
  48. 7.8.5 BD Recent Developments
  49. 7.9 JNJ
  50. 7.9.1 JNJ Company Information
  51. 7.9.2 JNJ Business Overview
  52. 7.9.3 JNJ In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 JNJ In-Vitro Diagnostics Product Portfolio
  54. 7.9.5 JNJ Recent Developments
  55. 7.10 Sysmex
  56. 7.10.1 Sysmex Company Information
  57. 7.10.2 Sysmex Business Overview
  58. 7.10.3 Sysmex In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
  60. 7.10.5 Sysmex Recent Developments
  61. 7.11 KHB
  62. 7.11.1 KHB Company Information
  63. 7.11.2 KHB Business Overview
  64. 7.11.3 KHB In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 KHB In-Vitro Diagnostics Product Portfolio
  66. 7.11.5 KHB Recent Developments
  67. 7.12 DaAn Gene
  68. 7.12.1 DaAn Gene Company Information
  69. 7.12.2 DaAn Gene Business Overview
  70. 7.12.3 DaAn Gene In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
  72. 7.12.5 DaAn Gene Recent Developments
  73. 7.13 Leadman
  74. 7.13.1 Leadman Company Information
  75. 7.13.2 Leadman Business Overview
  76. 7.13.3 Leadman In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Leadman In-Vitro Diagnostics Product Portfolio
  78. 7.13.5 Leadman Recent Developments
  79. 7.14 BioSino
  80. 7.14.1 BioSino Company Information
  81. 7.14.2 BioSino Business Overview
  82. 7.14.3 BioSino In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  83. 7.14.4 BioSino In-Vitro Diagnostics Product Portfolio
  84. 7.14.5 BioSino Recent Developments
  85. 7.15 BSBE
  86. 7.15.1 BSBE Company Information
  87. 7.15.2 BSBE Business Overview
  88. 7.15.3 BSBE In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  89. 7.15.4 BSBE In-Vitro Diagnostics Product Portfolio
  90. 7.15.5 BSBE Recent Developments
  91. 7.16 Maccura
  92. 7.16.1 Maccura Company Information
  93. 7.16.2 Maccura Business Overview
  94. 7.16.3 Maccura In-Vitro Diagnostics Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Maccura In-Vitro Diagnostics Product Portfolio
  96. 7.16.5 Maccura Recent Developments
8 North America
  1. 8.1 North America In-Vitro Diagnostics Revenue (2021-2032)
  2. 8.2 North America In-Vitro Diagnostics Revenue by Type (2021-2032)
  3. 8.2.1 North America In-Vitro Diagnostics Revenue by Type (2021-2026)
  4. 8.2.2 North America In-Vitro Diagnostics Revenue by Type (2027-2032)
  5. 8.3 North America In-Vitro Diagnostics Revenue Share by Type (2021-2032)
  6. 8.4 North America In-Vitro Diagnostics Revenue by Application (2021-2032)
  7. 8.4.1 North America In-Vitro Diagnostics Revenue by Application (2021-2026)
  8. 8.4.2 North America In-Vitro Diagnostics Revenue by Application (2027-2032)
  9. 8.5 North America In-Vitro Diagnostics Revenue Share by Application (2021-2032)
  10. 8.6 North America In-Vitro Diagnostics Revenue by Country
  11. 8.6.1 North America In-Vitro Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America In-Vitro Diagnostics Revenue by Country (2021-2026)
  13. 8.6.3 North America In-Vitro Diagnostics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe In-Vitro Diagnostics Revenue (2021-2032)
  2. 9.2 Europe In-Vitro Diagnostics Revenue by Type (2021-2032)
  3. 9.2.1 Europe In-Vitro Diagnostics Revenue by Type (2021-2026)
  4. 9.2.2 Europe In-Vitro Diagnostics Revenue by Type (2027-2032)
  5. 9.3 Europe In-Vitro Diagnostics Revenue Share by Type (2021-2032)
  6. 9.4 Europe In-Vitro Diagnostics Revenue by Application (2021-2032)
  7. 9.4.1 Europe In-Vitro Diagnostics Revenue by Application (2021-2026)
  8. 9.4.2 Europe In-Vitro Diagnostics Revenue by Application (2027-2032)
  9. 9.5 Europe In-Vitro Diagnostics Revenue Share by Application (2021-2032)
  10. 9.6 Europe In-Vitro Diagnostics Revenue by Country
  11. 9.6.1 Europe In-Vitro Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe In-Vitro Diagnostics Revenue by Country (2021-2026)
  13. 9.6.3 Europe In-Vitro Diagnostics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China In-Vitro Diagnostics Revenue (2021-2032)
  2. 10.2 China In-Vitro Diagnostics Revenue by Type (2021-2032)
  3. 10.2.1 China In-Vitro Diagnostics Revenue by Type (2021-2026)
  4. 10.2.2 China In-Vitro Diagnostics Revenue by Type (2027-2032)
  5. 10.3 China In-Vitro Diagnostics Revenue Share by Type (2021-2032)
  6. 10.4 China In-Vitro Diagnostics Revenue by Application (2021-2032)
  7. 10.4.1 China In-Vitro Diagnostics Revenue by Application (2021-2026)
  8. 10.4.2 China In-Vitro Diagnostics Revenue by Application (2027-2032)
  9. 10.5 China In-Vitro Diagnostics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia In-Vitro Diagnostics Revenue (2021-2032)
  2. 11.2 Asia In-Vitro Diagnostics Revenue by Type (2021-2032)
  3. 11.2.1 Asia In-Vitro Diagnostics Revenue by Type (2021-2026)
  4. 11.2.2 Asia In-Vitro Diagnostics Revenue by Type (2027-2032)
  5. 11.3 Asia In-Vitro Diagnostics Revenue Share by Type (2021-2032)
  6. 11.4 Asia In-Vitro Diagnostics Revenue by Application (2021-2032)
  7. 11.4.1 Asia In-Vitro Diagnostics Revenue by Application (2021-2026)
  8. 11.4.2 Asia In-Vitro Diagnostics Revenue by Application (2027-2032)
  9. 11.5 Asia In-Vitro Diagnostics Revenue Share by Application (2021-2032)
  10. 11.6 Asia In-Vitro Diagnostics Revenue by Country
  11. 11.6.1 Asia In-Vitro Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia In-Vitro Diagnostics Revenue by Country (2021-2026)
  13. 11.6.3 Asia In-Vitro Diagnostics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA In-Vitro Diagnostics Revenue (2021-2032)
  2. 12.2 SAMEA In-Vitro Diagnostics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA In-Vitro Diagnostics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA In-Vitro Diagnostics Revenue by Type (2027-2032)
  5. 12.3 SAMEA In-Vitro Diagnostics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA In-Vitro Diagnostics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA In-Vitro Diagnostics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA In-Vitro Diagnostics Revenue by Application (2027-2032)
  9. 12.5 SAMEA In-Vitro Diagnostics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA In-Vitro Diagnostics Revenue by Country
  11. 12.6.1 SAMEA In-Vitro Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA In-Vitro Diagnostics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA In-Vitro Diagnostics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst